跳至主要内容
临床试验/NCT01642498
NCT01642498已完成3 期

ROX CONTROL HTN Study: A Prospective, Randomized, Open-Label, Multicenter Study to Evaluate the ROX Coupler in Patients With Resistant Hypertension

ROX Medical, Inc.18 个研究点 分布在 7 个国家目标入组 100 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
100
试验地点
18
主要终点
Change in mean office SBP

研究概览

简要总结

The purpose of this study is to evaluate the safety and performance of the ROX COUPLER in patients with treatment-resistant hypertension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of treatment-resistant hypertension must be made on the basis of current findings, medical history, and physical examination

排除标准

  • •Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.

研究组 & 干预措施

Group A

Experimental

ROX Coupler + continuing standard antihypertensive medications

干预措施: ROX COUPLER (Device)

Group B

No Intervention

Continuing standard antihypertensive medications

结局指标

主要结局

Change in mean office SBP

时间窗: Baseline, 6 months

Change in mean office SBP at six months as compared to Baseline

次要结局

  • Change in mean office DBP(Baseline, 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验

A Multicenter Study to Evaluate the ROX... | 临床试验